<code id='1A4F6457F9'></code><style id='1A4F6457F9'></style>
    • <acronym id='1A4F6457F9'></acronym>
      <center id='1A4F6457F9'><center id='1A4F6457F9'><tfoot id='1A4F6457F9'></tfoot></center><abbr id='1A4F6457F9'><dir id='1A4F6457F9'><tfoot id='1A4F6457F9'></tfoot><noframes id='1A4F6457F9'>

    • <optgroup id='1A4F6457F9'><strike id='1A4F6457F9'><sup id='1A4F6457F9'></sup></strike><code id='1A4F6457F9'></code></optgroup>
        1. <b id='1A4F6457F9'><label id='1A4F6457F9'><select id='1A4F6457F9'><dt id='1A4F6457F9'><span id='1A4F6457F9'></span></dt></select></label></b><u id='1A4F6457F9'></u>
          <i id='1A4F6457F9'><strike id='1A4F6457F9'><tt id='1A4F6457F9'><pre id='1A4F6457F9'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:9173
          Bruce Broussard. -- health business coverage from STAT
          Humana CEO Bruce Broussard Jason DeCrow/AP

          Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

          Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

          advertisement

          Humana’s stock fell by more than 2% on the news Wednesday morning.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          As pharma fights Medicare drug negotiation, hospitals, docs silent
          As pharma fights Medicare drug negotiation, hospitals, docs silent

          AdobeThepharmaceuticalindustryhasbeenupinarmsoverMedicare’sfirstlistof10prescriptiondrugsthatwillbes

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

          CTscansshowedthatthepatientinitiallyrespondedtolorlatinib(left).Buteightmonthslater,themetastaticliv